SMILES: Study of Montelukast in Sickle Cell Disease

NCT04351698 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Anemia, Sickle Cell
Sleep-Disordered Breathing

Interventions

DRUG: Montelukast
OTHER: Oral Placebo

Sponsor

Great Ormond Street Hospital for Children NHS Foundation Trust

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]